Credits Available: 4.75 hours of AMA PRA Category 1 Credit™ with ABIM MOC

Description: This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Oncology, Hematology/Oncology

Christopher Del Prete

Stamford Health

Dr. Christopher Del Prete grew up in Connecticut and completed medical school at the University of Connecticut, internal medicine residency at Dartmouth-Hitchcock Medical Center, and hematology/oncology fellowship at Brown University. Dr. Del Prete enjoys teaching and learning with a goal of improving patient outcomes.